Transcriptomics and AI-driven approaches to the diagnosis and treatment of rheumatoid arthritis

Marzena Ciechomska1, Maciej Oldak1,2,3, Magdalena Massalska1

  • 1Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology, and Rehabilitation (NIGRiR), Warsaw, Poland.

Insights

Dysregulated RNA expression drives rheumatoid arthritis (RA) progression. Integrating transcriptomics, spatial technologies, and machine learning aids discovery of biomarkers and cell targets for precision medicine in RA.

Area of Science:

  • Rheumatology and Immunology
  • Genomics and Bioinformatics
  • Computational Biology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and destruction.
  • Aberrant RNA expression significantly contributes to RA pathogenesis by altering cellular functions.
  • Transcriptomic signatures hold potential as biomarkers for RA diagnosis, prognosis, and treatment stratification.

Purpose of the Study:

  • To review advancements in transcriptomic technologies for understanding RA.
  • To highlight the role of computational and machine learning methods in biomarker discovery for RA.
  • To discuss the integration of transcriptomics, spatial technologies, and algorithms for precision medicine in RA.

Main Methods:

  • Bulk RNA sequencing to identify key pathways and molecular signatures in RA.
  • Single-cell transcriptomics to analyze cellular heterogeneity and identify disease-implicated cell populations.
  • Spatial transcriptomics to map cellular interactions within inflamed tissues.
  • Machine learning algorithms (e.g., Random Forest, XGBoost, SVM, ANNs, LASSO) for feature selection and prediction.
  • Network and pathway analysis tools (e.g., WGCNA, GSVA) to uncover co-regulated gene modules.

Main Results:

  • Transcriptomic profiling has revealed critical dysregulated pathways and molecular signatures in RA.
  • Single-cell analyses have identified extensive cellular heterogeneity and rare cell populations involved in RA.
  • Spatial transcriptomics enables precise localization of pathogenic cell states and mapping of cell-cell interactions.
  • Integration with computational methods accelerates the discovery of predictive biomarkers and therapeutic targets.

Conclusions:

  • The integration of transcriptomics, spatial technologies, and advanced algorithms provides powerful tools for RA research.
  • Novel biomarkers and pathogenic cell populations can be identified to advance precision medicine approaches for RA.
  • These integrated approaches are transforming the understanding and management of rheumatoid arthritis.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K